Vaccinations and multiple sclerosis

Neurological Sciences

Volumn 22, Issue 2, 2001, Pages 151-154

  Gout, O ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Hepatitis B; Multiple sclerosis; Vaccination

Indexed keywords

HEPATITIS B VACCINE; INFLUENZA VACCINE; VACCINE;

ALLERGIC ENCEPHALITIS; ANTIGEN BINDING; BACTERIAL INFECTION; CONFERENCE PAPER; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DRUG SURVEILLANCE PROGRAM; GRAY MATTER; HEALTH CARE POLICY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTE; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; MYELITIS; NEUROPATHOLOGY; NEUROTOXICITY; OPTIC NERVE DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PERTUSSIS; POSTVACCINAL ENCEPHALITIS; RISK ASSESSMENT; TETANUS; VACCINATION; VIRUS INFECTION; WHITE MATTER; YELLOW FEVER;

AGE FACTORS; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HEPATITIS B VACCINES; HUMANS; MALE; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; RISK FACTORS; SEX FACTORS; VACCINATION;

EID: 0034798466     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720170014     Document Type: Conference Paper

References (15)

1. Miller H, Cendrowski W, Schapira K ( 1967) Multiple sclerosis and vaccination. Br Med J 2:210-213
2. Myers L, Ellison G (1976) Swine-influenza vaccination in multiple sclerosis. N Engl J Med 295:1204
3. Miller A, Morgante L, Buchwald L et al ( 1997) A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 48:312-331
4. Michielsens B, Wilms G, Marchai G et al (1990) Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination. Eur Neurol 30:248-259
5. Salvetti M, Pisani A, Bastianello S et al (1995) Clinical and MRt assessment of disease activity in patients with multiple. sclerosis after influenza vaccination. J Neurol 242:143-146
6. Quast U, Herder C, Zwisler O ( 1991 ) Vaccination of patients with encephalomyelitis disseminata. Vaccine 9:228-230
7. Gout O, Théodorou I, Liblau R et al (1997) Central nervous system demyelination after recombinant hepatitis B vaccination report of 25 cases. Neurology 48[Suppl 2]:A424
8. Gout O, Lyon-Caen O (1998) Sclérose en plaques et vaccination contre le virus de l'hépatite B. Rev Neurol (Paris) 154:205-207
9. Tourbah A, Gout O, Liblau R et al (1999) Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 53:396-401
10. Touzé E, Gout O, Verdier-Taillefer M et al (2000) First central nervous system demyelination and hepatitis B vaccination: a pilot case control study. Rev Neurol (Paris) 156:242-246
11. Sturkenboom M, Wolfson C, Gout O et al (2000) Demyclination, multiple selerosis and hepatitis B vaccination: a population-based study in the UK. Neurology 54[Suppl 3]:AI66
12. Coutans M, Brunei P, De Mareo O et al (2000) Demyelinating disease and hepatitis B vaccination: survey of 735 patients seen at MS Clinic. Neurology 54[Suppl 3]:A166
13. Fujinami R, Oldstone M (1985) Arnino acid homology between encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230:1043-1045
14. Gran B, Bielekova B. McFarland H et al (2000) Development of multiple selerosis after hepatitis B vaccination: an immunologie case report. Neurology 54[Suppl 3j:A164
15. Gherardi R, Coquet M, Chérin P el al (2000) Macrophagic myofasciitis: a reaction to intramuscular injection of aluminum-containing vaccine. Neurology 54[Suppl 3]:A439